tiprankstipranks
Trending News
More News >
Cellectar Biosciences (CLRB)
NASDAQ:CLRB
US Market
Advertisement

Cellectar Biosciences (CLRB) Income Statement

Compare
1,431 Followers

Cellectar Biosciences Income Statement

Last quarter (Q2 2025), Cellectar Biosciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Cellectar Biosciences's net income was $-5.45M. See Cellectar Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 51.78M$ 38.96M$ 28.81M$ 24.13M$ 15.29M
Depreciation and Amortization
$ 291.65K$ 192.38K$ 148.44K$ 149.91K$ 207.93K
EBITDA
$ -51.49M$ -38.77M$ -28.67M$ -23.98M$ -14.89M
Operating Income
$ -51.78M$ -38.96M$ -28.81M$ -24.13M$ -15.29M
Other Income/Expenses
$ 7.26M$ -3.87M$ -3.04M$ 8.92K$ 196.18K
Pretax Income
$ -44.52M$ -42.83M$ -31.85M$ -24.12M$ -15.09M
Net Income
$ -44.58M$ -42.77M$ -31.79M$ -24.12M$ -15.09M
Per Share Metrics
Basic EPS
$ -40.72$ -104.92$ -473.55$ -130.35$ -228.55
Diluted EPS
$ -45.38$ -104.92$ -473.55$ -130.35$ -228.55
Weighted Average Shares Outstanding
1.54M 647.37K 310.20K 185.05K 66.04K
Weighted Average Shares Outstanding (Diluted)
1.54M 647.37K 310.20K 185.05K 66.04K
Currency in USD

Cellectar Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis